This is a light microscopy histology image of thyroid gland tissue prepared with a Romanowsky-type stain (e.g., Diff-Quik/Wright-Giemsa). The specimen shows normal-appearing follicular epithelium arranged in intact macrofollicles with abundant colloid occupying the luminal spaces. Follicular cells are evenly spaced with uniform, round to oval nuclei and scant to moderate cytoplasm, consistent with well-differentiated thyroid epithelium. The colloid background is pale blue and prominent, reflecting thyroglobulin-containing material released from follicles. The architectural pattern emphasizes large follicle units with a single layer of cuboidal to low-columnar epithelium surrounding expansive colloid pools. No prominent nuclear features of papillary carcinoma are evident, and there is no marked cellular atypia or mitotic activity in the visible fields. This image illustrates classic histology of benign thyroid tissue or colloid-rich goiter, useful for teaching follicular morphologies, thyroid folliculogenesis, and colloid dynamics. Clinically, such samples are evaluated in the context of thyroid nodules and goiter workups, with correlation to serum thyroid function tests and, when applicable, ultrasound or FNA findings. Potential educational uses include cytology-histology correlation, differential diagnosis of thyroid disease, and artifact recognition in Romanowsky-stained preparations. Images are suitable for medical education, pathology review, and database indexing. Correlative data improve student comprehension and diagnostic recall greatly.

This is a light micrograph of thyroid gland tissue prepared for histopathology and stained with Hematoxylin and Eosin (H&E). The sample reveals multiple spherical to irregular follicles of varying size separated by wispy fibrous septa. The colloid-filled lumens are pink to pale pink, while the surrounding follicular epithelium is a uniform single layer of cuboidal to low-columnar cells with round to oval nuclei and inconspicuous nucleoli. No nuclear grooves, inclusions, or pseudoinclusions characteristic of papillary carcinoma are evident. The stromal background is relatively scant with no dense lymphocytic infiltrate or Hurthle cell metaplasia apparent. The architecture is reminiscent of normal thyroid parenchyma or benign nodular colloid goiter pattern, where follicle size varies and colloid predominates. There are no mitotic figures or cytologic atypia observed. This image demonstrates classic histology of endocrine gland tissue with preserved colloid and regular follicle lining, suitable as reference for normal thyroid architecture in educational, diagnostic, and research contexts. Clinically, such histology supports benign thyroid pathology when correlated with imaging and labs. In malignant differentials, absence of papillary nuclear features or tall columnar cells argues against papillary thyroid carcinoma; however, definitive diagnosis should consider capsule invasion and margin status in surgical specimens.

Histology image obtained from thyroid tissue showing medullary thyroid carcinoma with extracellular amyloid deposits in the tumor stroma and a foreign body-type giant cell reaction surrounding the amyloid. The slide is a paraffin-embedded tissue section stained with Hematoxylin and Eosin, visualized under light microscopy. The malignant parafollicular C-cells form nests and sheets with uniform, round to polygonal cells and granular cytoplasm, displaying salt-and-pepper nuclear characteristics. A conspicuous, pink, amorphous extracellular matrix represents calcitonin-derived amyloid within and around tumor nests; multinucleated giant cells and macrophages are present at the periphery, reflecting a foreign body-type granulomatous response to amyloid deposition. Congo red staining (not shown here) would typically reveal apple-green birefringence under polarized light, confirming amyloid. This histology is characteristic of medullary thyroid carcinoma (MTC) and helps distinguish it from papillary, follicular, or anaplastic thyroid cancers. Diagnostic significance rests on the co-occurrence of C-cell neoplasia and amyloid, a hallmark of MTC, with possible associations to calcitonin gene-related peptide and RET oncogene alterations. Clinically, MTC presents with a neck mass and elevated serum calcitonin and CEA; amyloid-rich stroma reflects tumor biology and has prognostic implications. The image supports educational and diagnostic use in pathology, endocrine oncology, and medical education.

Imaging modality and technique: Light microscopy of a hematoxylin and eosin (H&E) stained thyroid tumor section, viewed at high magnification (~400x). Anatomical context: thyroid gland in the neck, parafollicular C-cell-derived medullary thyroid carcinoma. Observed architectures include diffuse growth in broad sheets, as well as solid nests and anastomosing trabeculae. Tumor cells show high-grade nuclei with conspicuous nucleoli and abundant eosinophilic cytoplasm; cytoplasmic borders are indistinct, imparting a syncytial appearance. There is little to no glandular differentiation or intraductal component. A striking, prominent lympho-plasmacytic infiltrate surrounds and permeates the tumor, a hallmark histologic feature of MTC. Background stroma may contain stromal amyloid in some cases (not always visible). Immunophenotypic expectation (not depicted): calcitonin and neuroendocrine markers positive; CEA may be expressed; TTF-1 variably positive. Diagnostic significance: the described morphology is characteristic of medullary thyroid carcinoma and helps distinguish it from papillary, follicular, anaplastic, and poorly differentiated thyroid carcinomas or metastatic neuroendocrine tumors. Clinical correlation: assess serum calcitonin and CEA; evaluate for MEN2 syndrome; RET mutation testing; imaging for primary tumor and metastasis; consider therapeutic implications and prognosis. Educational use: reference histology slide illustrating C-cell origin, syncytial tumor cells, and lymphoplasmacytic response. Correlation with amyloid deposition and calcitonin positivity may aid diagnostically.

A pathophysiology diagram illustrating the seven-step process of thyroid hormone synthesis (T3 and T4) across three compartments: Blood, Thyrocyte, and Colloid. (1) Iodine uptake: Iodide (I-) enters the thyrocyte from the blood via the Sodium/Iodide Symporter (NIS). (2) TG secretion: Thyroglobulin (TG) is secreted into the colloid. (3) Iodination: Within the colloid, iodide is oxidized by Thyroid Peroxidase (TPO), dual oxidase (DUOX), and H2O2, leading to the attachment of iodine to tyrosine residues on TG. (4) T4 synthesis: A coupling reaction occurs between 'Donor' and 'Acceptor' iodinated tyrosine residues on the TG scaffold. (5) Endocytosis: The modified TG molecule is re-absorbed into the thyrocyte. (6) Proteolysis: Lysosomal enzymes break down TG, releasing individual hormones. (7) Release: Free T4 (thyroxine) and T3 (triiodothyronine) are secreted into the blood for systemic distribution to organs. The diagram includes detailed chemical structures of the phenolic rings and iodine substitutions characteristic of thyroid hormones.

A multi-panel figure illustrating the clinical history and diagnostic findings of a patient with radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC). Panel A is a dual-axis timeline graph (Sept-2009 to Feb-2017) tracking serum Thyroglobulin (Tg) in ng/mL and Thyroid Stimulating Hormone (TSH) in uIU/mL alongside major interventions, including subtotal thyroidectomy, bilateral neck dissections, and multiple RAI treatments (100mCi each). Panels B and C show Radioactive Iodine (RAI) whole-body scans in anterior and posterior views. Scan B reveals functional iodine uptake in the neck, while Scan C demonstrates a lack of neck uptake but a new abnormal focus in the anterior-inferior mediastinum. Panel D provides localized anterior/posterior views clarifying the mediastinal focus. Panel E and F present histopathological sections: E shows Hematoxylin and Eosin (HE) staining at 200x magnification confirming papillary thyroid carcinoma morphology with papillary architecture; F shows immunohistochemical staining for Ki67, indicating a proliferative index of approximately 10%. The composite illustrates the progression of PTC from initial diagnosis through the development of RAI-refractoriness.

This composite educational image illustrates the longitudinal treatment response of a 68-year-old female with differentiated thyroid cancer and 131I-avid pulmonary metastases. Panel (A) displays a series of five anterior whole-body radioactive iodine (131I) scans following five successive courses of radioiodine therapy (RT). The initial scan shows intense, diffuse bilateral pulmonary uptake and thyroid bed activity. Successive scans demonstrate a progressive reduction in tracer avidity, signifying therapeutic response and decreased tumor burden. Panels (B), (C), and (D) provide quantitative correlation through line graphs. Graph B shows the maximum target-to-background ratio (T/Bmax) declining from 31.0 to 6.3. Graph C tracks the thyroid stimulating hormone-suppressed thyroglobulin (Tgon) levels, showing a significant decrease from 521.0 ng/mL to 132.0 ng/mL. Graph D illustrates the change rate of Tgon level (ΔTgon%), which peaks at 34.2% in the second course before dropping to 3.2% by the fifth course. This multimodal representation highlights the transition from biochemical remission to potential radioiodine refractoriness in late-stage treatment.